A detailed history of California State Teachers Retirement System transactions in 4 D Molecular Therapeutics, Inc. stock. As of the latest transaction made, California State Teachers Retirement System holds 28,490 shares of FDMT stock, worth $586,324. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28,490
Previous 25,293 12.64%
Holding current value
$586,324
Previous $512,000 77.15%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$17.03 - $35.87 $54,444 - $114,676
3,197 Added 12.64%
28,490 $907,000
Q4 2023

Feb 13, 2024

SELL
$9.76 - $21.25 $18,212 - $39,652
-1,866 Reduced 6.87%
25,293 $512,000
Q3 2023

Nov 14, 2023

SELL
$12.64 - $19.76 $106,643 - $166,715
-8,437 Reduced 23.7%
27,159 $345,000
Q2 2023

Aug 21, 2023

BUY
$15.16 - $23.26 $133,226 - $204,408
8,788 Added 32.78%
35,596 $643,000
Q1 2023

May 09, 2023

BUY
$15.45 - $23.19 $229,092 - $343,861
14,828 Added 123.77%
26,808 $460,000
Q4 2022

Feb 14, 2023

SELL
$6.85 - $25.46 $160,899 - $598,029
-23,489 Reduced 66.22%
11,980 $266,000
Q3 2022

Nov 18, 2022

SELL
$6.96 - $11.48 $4,273 - $7,048
-614 Reduced 1.7%
35,469 $285,000
Q2 2022

Aug 15, 2022

BUY
$5.68 - $15.99 $18,954 - $53,358
3,337 Added 10.19%
36,083 $252,000
Q1 2022

May 16, 2022

SELL
$13.16 - $22.64 $37,742 - $64,931
-2,868 Reduced 8.05%
32,746 $495,000
Q4 2021

Feb 15, 2022

BUY
$19.56 - $32.94 $261,106 - $439,716
13,349 Added 59.96%
35,614 $781,000
Q3 2021

Nov 15, 2021

BUY
$22.73 - $36.04 $197,910 - $313,800
8,707 Added 64.22%
22,265 $600,000
Q2 2021

Aug 16, 2021

BUY
$22.2 - $42.29 $40,426 - $77,010
1,821 Added 15.52%
13,558 $326,000
Q1 2021

May 18, 2021

BUY
$35.94 - $52.67 $421,827 - $618,187
11,737 New
11,737 $509,000

Others Institutions Holding FDMT

About 4D Molecular Therapeutics, Inc.


  • Ticker FDMT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,382,400
  • Market Cap $666M
  • Description
  • 4D Molecular Therapeutics, Inc., a clinical-stage gene therapy company, develops product candidates using its adeno-associated viruses vectors. It develops a portfolio of gene therapy product candidates focuses in three therapeutic areas: ophthalmology, cardiology, and pulmonology. The company has three product candidates that are in clinical tr...
More about FDMT
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.